| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/10/2011 | WO2011028743A1 Pharmaceutical formulations for indibulin |
| 03/10/2011 | WO2011028651A1 Inhibitors of human 15-lipoxygenase-1 |
| 03/10/2011 | WO2011027916A1 Therapeutic agent for allergic diseases |
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof |
| 03/10/2011 | WO2011027807A1 Immunity inducer |
| 03/10/2011 | WO2010108657A3 C5a binding nucleic acids and the use thereof |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060041 Method of reversing, preventing, delaying or stabilizing soft tissue calcification |
| 03/10/2011 | US20110060026 Indoles Active on CRTH2 Receptor |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060016 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
| 03/10/2011 | US20110060010 Salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione and derivatives thereof, or polymorphs of salts, process for preparing same and use thereof |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110060004 Imidazo-Pyridine Derivatives as Activin-Like Receptor Kinase (ALK4 or ALK5) Inhibitors |
| 03/10/2011 | US20110059989 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059955 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 03/10/2011 | US20110059952 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 03/10/2011 | US20110059949 Prophylaxis and treatment of infectious diseases |
| 03/10/2011 | US20110059945 S1P Receptor Modulating Compounds and Use Thereof |
| 03/10/2011 | US20110059944 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059931 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/10/2011 | US20110059919 Antiviral composition comprising a sulfated polysaccharide |
| 03/10/2011 | US20110059916 Methods and Compositions for Inducing Torpor in a Subject |
| 03/10/2011 | US20110059908 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax |
| 03/10/2011 | US20110059885 Treatment of diseases and conditions mediated by eicosanoids |
| 03/10/2011 | US20110059190 Cistus extract containing enriched secondary plant ingredients |
| 03/10/2011 | US20110059125 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 03/10/2011 | US20110059118 Inhibitors of jak |
| 03/10/2011 | US20110059117 Liquid Compositions Capable of Foaming and Including Active Agents, and Methods for Making or Developing Same |
| 03/10/2011 | US20110059101 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling |
| 03/10/2011 | US20110059100 C/CLP Antagonists And Methods Of Use Thereof |
| 03/10/2011 | US20110059095 High affinity human antibodies to human protease-activated receptor-2 |
| 03/10/2011 | US20110059068 Polypeptides involved in immune response |
| 03/10/2011 | US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides |
| 03/10/2011 | US20110059062 Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages |
| 03/10/2011 | US20110059044 Method of treating pulmonary disease with interferons |
| 03/10/2011 | US20110056492 Effective delivery of nanoparticles and micrometer-sized pharmaceutical aerosols to the lung through enhanced condensational growth |
| 03/10/2011 | CA2773083A1 Immunity-inducing agent |
| 03/10/2011 | CA2773033A1 Use of aerosolized levofloxacin for treating cystic fibrosis |
| 03/10/2011 | CA2772871A1 Pharmaceutical formulations for indibulin |
| 03/09/2011 | EP2292771A2 Sense mRNA therapy |
| 03/09/2011 | EP2292660A2 Human antibody molecules for IL-13 |
| 03/09/2011 | EP2292632A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/09/2011 | EP2292630A1 O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 03/09/2011 | EP2292622A1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/09/2011 | EP2292617A1 1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors |
| 03/09/2011 | EP2292614A1 Substituted pyrimidines as aurora kinase inhibitors |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292584A1 Levalbuterol L-hemitartrate salt and aerosol formulation thereof |
| 03/09/2011 | EP2292267A2 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 03/09/2011 | EP2292235A2 Methotrexate solutions |
| 03/09/2011 | EP2292234A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof |
| 03/09/2011 | EP2292215A2 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 03/09/2011 | EP2292209A2 Stable pharmaceutical composition comprising a pyramidine-sulfamide |
| 03/09/2011 | EP2291369A1 Phenyl and benzodioxinyl substituted indazoles derivatives |
| 03/09/2011 | EP2291359A1 Phenyl or pyridinyl substituted indazoles derivatives |
| 03/09/2011 | EP2291176A1 Steroid nebuliser formulation |
| 03/09/2011 | EP1971332B1 Use of tiotropium salts in the treatment of moderate persistent asthma |
| 03/09/2011 | EP1841735B1 Indoles useful in the treatment of inflammation |
| 03/09/2011 | EP1723136B1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 03/09/2011 | EP1513812B1 Substituted indoles |
| 03/09/2011 | EP1315513B1 "pseudo"-native chemical ligation |
| 03/09/2011 | CN1989962B Capsule comprising moguisteine |
| 03/09/2011 | CN1874757B Mucoactive agents for treating a pulmonary disease |
| 03/09/2011 | CN1651395B Borneol fatly acid ester derivative and preparation containing said derivative |
| 03/09/2011 | CN101984759A Modulation of factor 9 expression |
| 03/09/2011 | CN101983708A Traditional Chinese medicine for clearing lung and eliminating phlegm |
| 03/09/2011 | CN101983690A Novel traditional Chinese medicine for treating rhinocarcinoma |
| 03/09/2011 | CN101983685A Traditional Chinese medicine composition for treating qi-asthenia cough and preparation method thereof |
| 03/09/2011 | CN101983677A Medicament for treating epistaxis |
| 03/09/2011 | CN101983675A Traditional Chinese medicine composition for treating asthma and preparation method thereof |
| 03/09/2011 | CN101983674A External applied traditional Chinese medicine composition for treating tracheitis and preparation method thereof |
| 03/09/2011 | CN101983662A Traditional Chinese medicine composition for treating sore throat and preparation method thereof |
| 03/09/2011 | CN101983642A Traditional Chinese medicine composition for treating pharyngitis of children and preparation method thereof |
| 03/09/2011 | CN101983632A Compound Tilmicosin nanoemulsion antibacterial agent and preparation method thereof |
| 03/09/2011 | CN101618061B Medicine for treating chronic pharyngitis and preparation method thereof |
| 03/09/2011 | CN101306082B Houkangsan quality control method |
| 03/09/2011 | CN101249208B Proprietary Chinese medicine preparations for curing chronic emphraxis lung diseases |
| 03/09/2011 | CN101077103B Inflammation-diminishing and cough-controlling tea |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902360 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 03/08/2011 | US7902253 Isoflavone derivatives of tectorigenin, the preparation thereof and the antiviral medicine containing the same as an effective constituent |
| 03/08/2011 | US7902208 Treating allergic and inflammatory conditions |
| 03/08/2011 | US7902187 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2468691C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2460313C Bisphenylsulfanyl and sulphonate compounds and use thereof for elevating hdl cholesterol levels |
| 03/08/2011 | CA2449217C Process for cleaning hard gelatine capsules |
| 03/08/2011 | CA2432126C Complex of modafinil and cyclodextrin |
| 03/08/2011 | CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011025128A2 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024973A1 Therapeutic agent for rhinitis |